AI Optics
Overview
AI Optics, founded in 2020 and based in New York City, is a medical device and digital health company focused on preventing blindness using AI technology. The company has raised funding from investors like NextCorps Luminate and HealthTech Capital, and employs approximately 14 people. Co-founded by Luke Moretti, AI Optics specializes in handheld retinal screening devices that enable preventative healthcare by providing rapid disease detection during routine medical visits.
Recent Developments
- August 2024: AI Optics expanded its outreach in the New York healthcare market. The company launched its AI-powered retinal screening device at multiple healthcare institutions, promoting early detection of vision impairing diseases like diabetic retinopathy.
- April 2024: AI Optics secured $100,000 in seed funding as part of the Luminate Accelerator program. This investment focuses on scaling their distribution and enhancing product features with advanced AI capabilities.
- February 2024: AI Optics participated in the NYC Vision Health Fair, demonstrating their AI-driven device to improve accessibility to eye care services. This initiative aims at reducing the prevalence of undiagnosed vision conditions.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2020 |
| Headquarters | New York City, United States |
| Founders | Luke Moretti |
| Revenue | Approx. $2.06 million (2022) |
| Profits | $108,000 (2022) |
| Key Investors | NextCorps Luminate, HealthTech Capital |
| Industry | Medical Equipment Manufacturing |
| Number of Employees | 14 |
Early History
AI Optics was established in 2020 with the mission to integrate AI into healthcare for enhancing vision diagnostics. With an academic foundation from institutions like Vanderbilt University and NYU, founder Luke Moretti focused on leveraging AI to address the diagnostic challenges in retinal health. The company's development of a handheld device that screens for retinal diseases aims to democratize access to screening technology, particularly in under-resourced clinics.
Company Profile and Achievements
AI Optics centers its business model around its flagship product: an AI-powered retinal screening device. Its major achievements include:
- Regulatory Approvals: The company achieved significant milestones by gaining essential medical certifications for its devices.
- Technology: The device incorporates cutting-edge imaging and AI technologies that improve screening speed and accuracy, providing results within minutes.
- Partnerships and Collaborations: AI Optics has cultivated partnerships with healthcare providers to integrate its device into everyday medical routines.
- Recognition: Earned placements and acknowledgments in several tech incubators and startup accelerators, highlighting its innovative approach to healthcare technology.
Current Operations and Market Position
AI Optics operates in the healthcare industry with a focus on preventive digital health solutions. The company is currently expanding its product availability within the U.S., aiming for a broader market outreach through collaborations with healthcare providers. Their competitive edge lies in the device's accuracy, speed, and cost-effectiveness, which positions AI Optics ahead of traditional retinal diagnostic tools.
Conclusion
AI Optics is transforming retinal health diagnostics by making them more accessible and efficient. Its use of AI in medical devices not only democratizes access to vital health screening but also positions the company as a potential market leader in AI-integrated healthcare solutions. The company's future will likely involve expanding its technological capabilities and geographical reach, further solidifying its impact on the healthcare industry.